Skip to main content
logo
Alterola Biotech, Inc. (ABTI)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Aug 21, 2026, 4:00 PM EST

Alterola Biotech Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
-2.78-2.37-2.07-6.47-0.31
Stock-Based Compensation
0.340.540.85.760.24
Change in Inventory
-0-00-0-
Change in Accounts Payable
0.090.220.070.44-
Change in Other Net Operating Assets
0.240.17-0.110.310.02
Operating Cash Flow
-2.32-1.45-1.310.04-0.05
Operating Cash Flow Growth
-----

Financing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21
Short-Term Debt Issued
-1.471.15-0.05
Long-Term Debt Issued
---0.16-
Total Debt Issued
3.721.471.150.160.05
Short-Term Debt Repaid
----0.54-
Total Debt Repaid
-1.06---0.54-
Net Debt Issued (Repaid)
2.661.471.15-0.380.05
Issuance of Common Stock
0.21-0.050.37-
Other Financing Activities
-0.16---0-
Financing Cash Flow
2.721.471.2-0.010.05

Net Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21
Foreign Exchange Rate Adjustments
-0.23-0.030.050.03-
Net Cash Flow
0.07-0.01-0.050.06-

Free Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21
Levered Free Cash Flow
-2.13-0.43-0.511.91-
Unlevered Free Cash Flow
-1.92-0.43-0.511.91-

Additional Metrics

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21
Change in Working Capital
0.330.39-0.040.760.02